warning icon
YOUR BROWSER IS OUT OF DATE!

This website uses the latest web technologies so it requires an up-to-date, fast browser!
Please try Firefox or Chrome!

generic viagraBrand Viagra is ruling the pharmaceutical world from the time it was introduced in to the market. From then till now, there are many generic manufacturers waiting for the patent of Viagra to end. It still has three more years for that; it means the patent of this erectile dysfunction medication would end at 2020. However, there is good news that Teva pharmaceuticals would be allowed to make the generic version of this medication.

Generic Viagra on December 11, 2017

Teva pharmaceutical is an Israel based drug company which is lucky enough to get this opportunity. On December 11, 2017 the generic Viagra would be introduced in to the market for usage by the people.

Pfizer has allowed only this company to invent a copycat version of the most popular impotency medication in the market. It is sure that most of the people both in the United States and other parts of the world are eagerly waiting for the generic version of Viagra.

Brand Viagra VS Generic Viagra

Pfizer was always keen on protecting their patent as they know that once it ends they would only get fewer profits from the medication. Last year, the brand form of the drug had a sales profit of $1.15 billion in the United States whereas it achieved $2 billion sale record worldwide.

When the generic version of the Viagra is introduced in the market, customers would move from brand to generic. Customers know that the effectiveness it provides on erectile dysfunction would be similar to the brand pills but the rate of these pills would be very affordable.

The brand pill can be purchased for $60 whereas it is possible to get generic pill at a rate of $2. It is possible for an impotent person to get the generic Viagra for the whole treatment at the price of getting a single brand Viagra medication.

What would be the loss for Pfizer Company?

It is sure that there will still be people who get brand Viagra pills but most of them would only opt for its generic variant. In this case, the profit would be degraded at a greater extent. It would lessen from billion to million.

However, Pfizer would still be making good profits until 2020 because only a single generic manufacturing company is going to manufacture the copycat drug and we believe it is allowed only in the United States.

There would be a drop in the share price of Pfizer too at a greater extent. As far as now, the Pfizer share price has dropped to 8 cents whereas the Teva’s share price has increased up to 16 cents.

Only when the generic Viagra pills hit the market by the end of 2017, it is possible to know the scenario. The profit for Teva generic manufacturing company for sure would be high.

loading
×